NCT02494531View on ClinicalTrials.gov

Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET Imaging

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 12, 2015

Primary Completion Date

May 6, 2019

Study Completion Date

May 6, 2020

Conditions
Alzheimer Disease
Interventions
RADIATION

Fluorodeoxyglucose-PET

Fluorodeoxyglucose-PET performed within 2 months

RADIATION

florbetapir F 18-PET

florbetapir F 18-PET performed within 2 months

Trial Locations (1)

93000

Hospital Avicenne-Neurology, Bobigny

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02494531 - Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET Imaging | Biotech Hunter | Biotech Hunter